Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1755)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (13)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4172)
  2. Weinberg Fellows (2756)
  3. Hematologic Malignancies, Division of (2492)
  4. Solid Tumor Oncology Division (2422)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (343)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4491)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study
    Research Letter

    Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AML
    Journal Article

    Alhajahjeh, A.; Patel, K. K.; Shallis, R. M.; Podoltsev, N. A.; Kewan, T.; Stempel, J. M.; Mendez, L.; Huntington, S. F.; Stahl, M.; Goshua, G.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Autogene cevumeran with or without atezolizumab in advanced solid tumors: A phase 1 trial
    Journal Article

    Lopez, J.; Powles, T.; Braiteh, F.; Siu, L. L.; LoRusso, P.; Friedman, C. F.; Balmanoukian, A. S.; Gordon, M.; Yachnin, J.; Rottey, S.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Research Letter

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
    Journal of the European Academy of Dermatology and Venereology (2025)

    Fulltext@MSK | Save
  • Outcomes after brexucabtagene autoleucel administered as a standard therapy for adults with relapsed/refractory B-cell ALL
    Journal Article

    Roloff, G. W.; Aldoss, I.; Kopmar, N. E.; Lin, C.; Dekker, S. E.; Gupta, V. K.; O’Connor, T. E.; Jeyakumar, N.; Muhsen, I. N.; Valtis, Y.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Quality of treatment selection for medicare beneficiaries with cancer
    Journal Article

    Mitchell, A. P.; Persaud, S.; Mishra Meza, A.; Fuchs, H. E.; De, P.; Tabatabai, S.; Chakraborty, N.; Dey, P.; Trivedi, N. U.; Mailankody, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
    Journal Article

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Treatment effectiveness of venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An International Real-World Study
    Research Letter

    Ghosh, N.; Eyre, T. A.; Brown, J. R.; Lamanna, N.; Manzoor, B. S.; Coombs, C. C.; Tuncer, H. H.; Ujjani, C.; Leslie, L. A.; Roeker, L. E.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save